CVE-2026-88075Configuration Manager Elevation of Privilege Vulnerability
Updated under an hour ago ()
Does this affect you?
It affects Microsoft Configuration Manager and 3 other products. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.64%, higher than 50% of scored CVEs.
Do this next
Free account, 1 product
Improper neutralization of special elements used in an sql command ('sql injection') in Microsoft Configuration Manager allows an authorized attacker to elevate privileges over a network.
- CVSS
- 8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H/E:U/RL:O/RC:C
- Weakness (CWE)
- CWE-89
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.64% (percentile 50)
- Assigned by
- microsoft
- NVD analysis
- Analyzed
- Record last updated
- Oct 16, 2026
- First seen by InfoSec Signals
- Oct 13, 2026
Affected products
Microsoft Microsoft Configuration Manager microsoft:configuration_manager (from the name) | from 1.0.0 before 5.00.9135.1040 | CNA record |
Microsoft Microsoft Configuration Manager 2509 microsoft:configuration_manager_2509 (from the name) | from 1.0.0 before 5.00.9141.1039 | CNA record |
Microsoft Microsoft Configuration Manager 2603 microsoft:configuration_manager_2603 (from the name) | from 1.0.0 before 5.00.9146.1026 | CNA record |
microsoft configuration_manager_2503 microsoft:configuration_manager_2503 | all versions | NVD |
microsoft configuration_manager_2509 microsoft:configuration_manager_2509 | all versions | NVD |
microsoft configuration_manager_2603 microsoft:configuration_manager_2603 | all versions | NVD |
References
- https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-88075vendor-advisory, patch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.